Prognostic value of the combination of serum l-kynurenine level and indoleamine 2,3-dioxygenase mRNA expression in acute myeloid leukemia

Takeshi HaraFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan;

Takuro MatsumotoFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan;

Yuhei ShibataFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan;

Nobuhiko NakamuraFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan;

Hiroshi NakamuraFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan;

Soranobu NinomiyaFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan;

Junichi KitagawaFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan;

Yasuhito NannyaFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan;

Masahito ShimizuFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan;

Hiroyasu ItoDepartment of Informative Clinical Medicine, Gifu University Graduate School of Medicine, Gifu, Japan;

Kuniaki SaitoDepartment of Human Health Sciences, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan

Hisashi TsurumiFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan; Correspondence[email protected]

Potential conflict of interest